Literature DB >> 7724047

Age-dependent increases of immunoreactive imidazoline receptors in the human brain: possible association of a 29/30 kDa protein with the I2-imidazoline receptor identified by [3H]idazoxan.

J A García-Sevilla1, M Sastre, P V Escribá.   

Abstract

In the postmortem human brain (15 specimens of frontal cortex), the immunodetection and quantification of imidazoline receptor (IR) proteins (29/30 and 47 kDa) and the specific binding of [3H]idazoxan to I2-IR were determined in parallel to study the effect of aging (range 3-89 years) on these proteins and its possible association. The immunoreactivity of the 29/30 kDa IR protein, similar to the I2-IR, showed a significant positive correlation with the age of the subjects at death (r = 0.54; P = 0.04). Moreover, the levels of this IR protein also correlated significantly with the density of I2-IR in the brain of the same subjects (r = 0.67; P = 0.01). It is suggested that the I2-IR labeled by [3H]idazoxan in the human brain is related to the 29/30 kDa IR protein identified by immunoblot analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724047     DOI: 10.1016/0304-3940(94)11188-o

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.

Authors:  Yonghua Zhang; Harold K Kimelberg
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

2.  The effect of alpha 2 adrenoceptor blockers on aggressive behavior in mice: implications for the actions of adrenoceptor agents.

Authors:  J Haller; G B Makara; J L Kovács
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

3.  Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.

Authors:  P V Escribá; R Alemany; M Sastre; G Olmos; A Ozaita; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.